We are live on ! Find out more
CRVO icon

CervoMed
CRVO

49 hedge funds and large institutions have $3.46M invested in CervoMed in 2024 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 10

6% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 16

2% less funds holding

Funds holding: 50 → 49 (-1)

24.48% less ownership

Funds ownership: 42.49% → 18.01% (-24%)

93% less capital invested

Capital invested by funds: $51.2M → $3.46M (-$47.7M)

Holders
49
Holders Change
-1
Holders Change %
-2%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
13
Reduced
10
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
+$728K
2
PWM
Perigon Wealth Management
California
+$610K
3
UBS Group
UBS Group
Switzerland
+$397K
4
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$272K
5
N
Nuveen
North Carolina
+$215K

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$11.9M
2
AIC
AWM Investment Company
New York
-$6.56M
3
AC
Armistice Capital
New York
-$5.87M
4
IC
Ikarian Capital
Texas
-$2.95M
5
SCM
Soleus Capital Management
Connecticut
-$1.85M
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
26
RhumbLine Advisers
Massachusetts
$10.1K -$2.41K -248 -5%
Mirae Asset Global ETFs Holdings
27
Mirae Asset Global ETFs Holdings
Hong Kong
$7.39K +$1.48K +152 +5%
CF
28
Corebridge Financial
Texas
$6.28K -$1.97K -203 -7%
Wells Fargo
29
Wells Fargo
California
$5.9K +$8.35K +859 +52%
TRCT
30
Tower Research Capital (TRC)
New York
$5.74K +$18.4K +1,897 +341%
Legal & General Group
31
Legal & General Group
United Kingdom
$4.95K – – –
HI
32
Hoey Investments
Pennsylvania
$2.53K – – –
Fidelity Investments
33
Fidelity Investments
Massachusetts
$2.46K -$27.3K -2,811 -73%
AIP
34
Ameritas Investment Partners
Nebraska
$1.24K – – –
New York State Common Retirement Fund
35
New York State Common Retirement Fund
New York
$936 – – –
Osaic Holdings
36
Osaic Holdings
Arizona
$924 – – –
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$915 – – –
Russell Investments Group
38
Russell Investments Group
United Kingdom
$536 -$9.39K -966 -81%
SS
39
SBI Securities
Japan
$363 +$1.51K +155 New
APW
40
Aventura Private Wealth
Florida
$159 +$661 +68 New
Nisa Investment Advisors
41
Nisa Investment Advisors
Missouri
$105 +$438 +45 New
SCM
42
Sterling Capital Management
North Carolina
$14 – – –
MWA
43
Medallion Wealth Advisors
Connecticut
$5 +$19 +2 New
AWM
44
Avior Wealth Management
Nebraska
$4 – – –
DB
45
Danske Bank
Denmark
$2 – – –
RCM
46
RA Capital Management
Massachusetts
– -$11.9M -817,120 Closed
AIC
47
AWM Investment Company
New York
– -$6.56M -449,006 Closed
AC
48
Armistice Capital
New York
– -$5.87M -402,000 Closed
IC
49
Ikarian Capital
Texas
– -$2.95M -202,345 Closed
SCM
50
Soleus Capital Management
Connecticut
– -$1.85M -126,614 Closed
1
2
3

CRVO Hedge Fund Activity: Q4 2024 in Review

49 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q4 2024, worth a combined $3.46M — down 93% from $51.2M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of CRVO and 15 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 13 added.

The largest buyer was Woodline Partners, opening a new position worth an estimated $728K. The largest seller was RA Capital Management, exiting entirely with an estimated $11.9M sold.

  • 49 institutional investors held CervoMed (CRVO) as of Q4 2024, down from 50 in Q3 2024.
  • Funds reported $3.46M of CervoMed stock for Q4 2024, down 93% quarter-over-quarter.
  • 15 funds opened new CervoMed positions in Q4 2024 and 16 closed out, a net change of -1 holder.
  • The largest CervoMed buyer in Q4 2024 was Woodline Partners, an estimated $728K added.
  • The largest CervoMed seller in Q4 2024 was RA Capital Management, an estimated $11.9M sold.

Based on aggregated 13F filings for Q4 2024.